findmyKOL

Lin Chang, MD

Enriched profile

Professor of Medicine; Vice Chief, Vatche and Tamar Manoukian Division of Digestive Diseases, UCLA · UCLA Health

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Los Angeles, CA · West · United StatesSpecialtyGastroenterologyFocusGastrointestinal motility and disorders+4
Active KOLfindmyKOL type: EliteLatest publication2025Online presenceverified 2026Payments2021–2025NIH funding1997–2026

Lin Chang is Professor of Medicine; Vice Chief, Vatche and Tamar Manoukian Division of Digestive Diseases, UCLA at UCLA Health. OpenAlex indexes 430 publications with 22,402 citations (h-index 78); ClinicalTrials.gov lists 12 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Gastroenterology profiles in the findmyKOL directory.

Data verified 21 Sept 2026

Overview

Updated 14 Oct 2026

Lin Chang, MD, is Professor of Medicine at UCLA Health / David Geffen School of Medicine at UCLA. The public record shows 430 publications with 22,402 citations (h-index 78), centered on Gastrointestinal motility and disorders, Congenital gastrointestinal and neural anomalies, Inflammatory Bowel Disease. It also documents an investigator role on 12 registered clinical trials, industry payments reported by 13 companies, 7 NIH-funded awards (1997–2026).

  • Most recent indexed publication: 2025 · Neurogastroenterology and motility
  • Top research focus: Gastrointestinal motility and disorders
  • 12 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 13 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
IBS / Functional GI5 trialsDiarrhea3 trialsEpilepsy1 trialSeizures1 trialRetinal Detachment1 trialNecrosis1 trialRetinal Necrosis Syndrome, Acute1 trialPain1 trialAbdominal Pain1 trialParesis1 trialGastroparesis1 trialDyspepsia1 trialBreast Cancer1 trialNeoplasm Metastasis1 trialAtrial Fibrillation1 trialArrhythmias, Cardiac1 trialFecal Incontinence1 trialIBD (Crohn's / UC)

Research focus

OpenAlex concept fingerprint
Gastrointestinal motility and disordersCongenital gastrointestinal and neural anomaliesInflammatory Bowel DiseaseGastroesophageal reflux and treatmentsMusic Therapy and Health

Drugs & molecules

across trials, industry payments and publications
Trulancegeneric · PlecanatideClinical trials—Industry payments6Publications1XIFAXANgeneric · RifaximinClinical trials—Industry payments13Publications—Ibsrelageneric · TenapanorClinical trials—Industry payments7Publications—Linzessgeneric · LinaclotideClinical trials—Industry payments2Publications—AbemaciclibClinical trials1Industry payments—Publications—AnastrozoleClinical trials1Industry payments—Publications—ExemestaneClinical trials1Industry payments—Publications—FulvestrantClinical trials1Industry payments—Publications—LetrozoleClinical trials1Industry payments—Publications—LY4064809Clinical trials1Industry payments—Publications—PalbociclibClinical trials1Industry payments—Publications—ResmetiromClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Eli Lilly and CompanyClinical trials1Industry payments3Salix Pharmaceuticals, a division of Bausch Health US, LLCClinical trials—Industry payments18Ardelyx, Inc.Clinical trials—Industry payments7AnX Robotica CorpClinical trials—Industry payments4University of California, Los AngelesClinical trials4Industry payments—Ironwood Pharmaceuticals, IncClinical trials—Industry payments3Abbvie Inc.Clinical trials—Industry payments2GlaxoSmithKline, LLC.Clinical trials—Industry payments2Menarini GroupClinical trials2Industry payments—Vibrant Gastro, Inc.Clinical trials—Industry payments2Boston Scientific CorporationClinical trials—Industry payments1Endogastric Solutions, IncClinical trials—Industry payments1ForConti MedicalClinical trials1Industry payments—Kaohsiung Medical University Chung-Ho Memorial HospitalClinical trials1Industry payments—Madrigal PharmaceuticalsClinical trials—Industry payments1Mauna Kea Technologies, Inc.Clinical trials—Industry payments1National Taiwan University HospitalClinical trials1Industry payments—Sigknow Biomedical Co., Ltd.Clinical trials1Industry payments—University of North Carolina, Chapel HillClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
430publications

Distinct works indexed by OpenAlex, matched via ORCID; 13 in PubMed.

22,402citations

Total citations across indexed works.

78h-index

Hirsch index (OpenAlex). i10-index 198.

Clinical & industry

trials, payments and federal funding
12clinical trials

Investigator role on registered studies.

View trials ↓
13companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
7NIH grants · 1997–2026

Federally funded research awards.

View funding ↓

Public positions

sourced statements on record
  • Member

    FDA Gastrointestinal Drugs Advisory Committee

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theromefoundation.org ↗
  • Member

    NIH Clinical, Integrative, and Molecular Gastroenterology (CIMG) Study Section

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theromefoundation.org ↗

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 12 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    58.9%
    Guanylate Cyclase-C Agonist22.2%
    Linzess100%
    Part D≥12 patients
    Serotonin-4 Receptor Agonist17.9%
    Motegrity100%
    Part D<11 patients

    + 3 more classes in this area

  • Nervous system

    41.1%
    Tricyclic Antidepressant14.6%
    Nortriptyline Hcl71%Desipramine Hcl30%
    Part D<11 patients
    SNRI9.3%
    Venlafaxine Hcl Er57%Savella43%
    Part D<11 patients

    + 4 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

7 NIH research awards on record, funded 1997–2026 per NIH RePORTER. The latest:

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Emeran A. Mayer153Bruce D. Naliboff111William D. Chey48Jennifer S. Labus43Wendy Shih40Brennan Spiegel38Elizabeth J. Videlock36Anthony Lembo35Kirsten Tillisch35Swapna Mahurkar‐Joshi35Arpana Gupta32Roger Bolus31Angela P. Presson27Lucinda A. Harris21Jonathan P. Jacobs18Charalabos Pothoulakis16Lisa A. Kilpatrick16Susan Lucak15Brian E. Lacy15Wendi G. LeBrett14Douglas A. Drossman14M. Mandelkern13Margaret Heitkemper13Tien S. Dong12Max J. Schmulson11Gregory S. Sayuk11Ron D. Hays11Dimitrios Iliopoulos11Adrienne Lenhart11Puja Khanna11Jennifer Talley10Michael Camilleri10Eric Esrailian10Gil Melmed10Dinesh Khanna10Jan Tack9Eric D. Shah9Hetal A. Karsan9Teresa I. Olivas9Venu Lagishetty9

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/lin-chang-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • X / Twitter

    x.com/LinChangMD

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Apple Podcasts

    podcasts.apple.com/us/podcast/dr-lin-chang-on-gi-health/id1567446832

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • X / Twitter

    X/Twitter handle @LinChangMD (attribution to this Lin Chang not independently confirmed on-profile)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    UCLA School of Medicine

    1986
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗

Editorial & leadership roles

journal and society appointments
  • Board Certified

    Gastroenterology, American Board of Internal Medicine

    1993
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
  • Board Certified

    Internal Medicine, American Board of Internal Medicine

    1989
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
  • Program Director

    UCLA GI Fellowship Program

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
  • Director

    Walter and Shirley Wang Center for Integrative Digestive Health, UCLA

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
  • Co-Director

    G. Oppenheimer Center for Neurobiology of Stress and Resilience, UCLA (also cited as Director elsewhere)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
  • Director

    Clinical Studies and Database Core, Goodman-Luskin Microbiome Center, UCLA

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
  • Past-President

    American Neurogastroenterology and Motility Society (ANMS)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theromefoundation.org ↗
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theromefoundation.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.